Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Kursexplosion von 383 % seit November und massiver Solana-Outperformer!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1J7TE | ISIN: CA43004Y1016 | Ticker-Symbol: C3H1
Frankfurt
22.01.25
08:00 Uhr
0,045 Euro
0,000
0,00 %
Branche
Rohstoffe
Aktienmarkt
Sonstige
1-Jahres-Chart
HIGHLAND COPPER COMPANY INC Chart 1 Jahr
5-Tage-Chart
HIGHLAND COPPER COMPANY INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0450,05318:09
GlobeNewswire (Europe)
234 Leser
Artikel bewerten:
(1)

Highland Copper Company Inc.: Highland Copper Commences Drilling Program for Metallurgical Testing of Ultrafine Flotation Technology

Finanznachrichten News

VANCOUVER, British Columbia, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Highland Copper Company Inc. (TSXV: HI; OTCQB: HDRSF) ("Highland Copper" or the "Company") is pleased to announce the commencement of a new drilling program aimed at extracting samples for advanced metallurgical testing. This initiative marks a significant step forward in optimizing project economics and underscores Highland Copper's commitment to innovative and sustainable mining practices.

The metallurgical testing forms part of the recently launched Front-End Engineering and Design work and will focus on ultra-fine flotation technology, a process that can potentially enhance the grade-recovery curve, resulting in improved overall project economics. In addition to potentially boosting recovery rates, this technology is also capable of delivering cost savings by reducing the physical footprint of the processing plant, aligning with the Company's goals for operational efficiency and environmental stewardship.

Barry O'Shea, CEO of Highland Copper, stated: "The launch of this drilling program represents an important milestone for Highland Copper as we continue to explore and implement innovative technologies. Ultra-fine flotation has the potential to not only enhance metal recovery but also reduce our environmental footprint, which is a core value of our operations. We are excited to consider how this proven technology can deliver long-term value to our shareholders and communities."

The drilling program is currently underway. The Company anticipates completing the program by mid-March 2025. The extracted samples will be tested in partnership with leading metallurgical laboratories to validate and refine the potential of ultra-fine flotation technology for the Company's operations.

Highland Copper remains committed to advancing its projects responsibly and efficiently, ensuring that innovation and sustainability are at the forefront of its strategic initiatives.

About Highland Copper Company

Highland Copper Company Inc. is a Canadian company focused on exploring and developing copper projects in the Upper Peninsula of Michigan, U.S.A. The Company owns the Copperwood deposit through long-term mineral leases and 34% of the White Pine North project through a joint venture with Kinterra Copper USA LLC. The Company also owns surface rights securing access to the Copperwood deposit and providing space for infrastructure at Copperwood as required. The Company has 736,363,619 common shares issued and outstanding. Its common shares are listed on the TSX Venture Exchange under the symbol "HI" and trade on the OTCQB Venture Market under the symbol "HDRSF."

More information about the Company is available on the Company's website at www.highlandcopper.com and on SEDAR+ at www.sedarplus.ca.

Cautionary Note Regarding Forward-Looking Information

This news release contains "forward-looking statements" and "forward-looking information" (collectively "forward-looking statements") within the meaning of applicable Canadian securities legislation. Forward-looking statements made in this news release include, without limitation, statements with respect to:(i) timing of the completion of the drilling program; (ii) the fact that the Company may be able to use ultra-fine flotation technology at Copperwood, and iii) the anticipated benefits of the use of ultra-fine flotation technology. There is no guarantee that the Copperwood project will be amenable to ultra-fine flotation technology, or that ultra-fine flotation technology will result in improved grade recovery, overall project economics, or a reduced environmental footprint. The work to be conducted is speculative in nature and part of the Company's ongoing FEED process at the Copperwood project. Although the Company believes that the assumptions and factors used in preparing the forward-looking statements in this news release are reasonable, undue reliance should not be placed on forward looking statements. All forward-looking statements in this press release are based on information available to the Company as of the date hereof, and the Company undertakes no obligation to update forward-looking statements except as required by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information or media requests, please contact:

Barry O'Shea, CEO
Email: info@highlandcopper.com
Website: www.highlandcopper.com


© 2025 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.